Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 23, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

July 31, 2029

Conditions
Gallbladder Adenocarcinoma
Interventions
DRUG

HIPEC

Heated Intra-Peritoneal Chemotherapy (HIPEC) HIPEC will be performed at the time of the index operation if a cancer is known pre-operatively, at the time of re-operation for incidentally discovered cancers already treated with cholecystectomy that are undergoing central hepatectomy and portal lymphadenectomy as part of standard of care, or independently if no other procedures are indicated. A closed technique will be utilized to deliver mitomycin C (MMC) over the first 60 minutes followed by an additional smaller dose over an additional 30 minutes. Perfusate will be heated to obtain a tissue temperature of 42°

Trial Locations (1)

26506

RECRUITING

West Virginia University Cancer Institute Mary Babb Randolph Cancer Center, Morgantown

All Listed Sponsors
lead

West Virginia University

OTHER